Stavroula Tsitkanou, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cachexia | 3 | 2024 | 202 | 1.220 |
Why?
|
Amyotrophic Lateral Sclerosis | 3 | 2024 | 1469 | 1.110 |
Why?
|
Muscular Atrophy | 3 | 2024 | 334 | 0.990 |
Why?
|
Plastoquinone | 1 | 2024 | 1 | 0.980 |
Why?
|
Hindlimb Suspension | 1 | 2023 | 75 | 0.860 |
Why?
|
Muscle, Skeletal | 6 | 2024 | 4948 | 0.820 |
Why?
|
TDP-43 Proteinopathies | 1 | 2021 | 38 | 0.770 |
Why?
|
Physical Conditioning, Animal | 1 | 2024 | 365 | 0.720 |
Why?
|
Muscle Contraction | 1 | 2024 | 1201 | 0.670 |
Why?
|
Adaptation, Physiological | 1 | 2024 | 1301 | 0.580 |
Why?
|
Muscle Fibers, Skeletal | 2 | 2019 | 542 | 0.560 |
Why?
|
Antioxidants | 1 | 2024 | 1668 | 0.540 |
Why?
|
DNA-Binding Proteins | 2 | 2024 | 9610 | 0.510 |
Why?
|
Mice, Inbred BALB C | 1 | 2024 | 6214 | 0.500 |
Why?
|
Quadriceps Muscle | 1 | 2016 | 156 | 0.490 |
Why?
|
Resistance Training | 1 | 2016 | 193 | 0.460 |
Why?
|
Muscle Strength | 1 | 2016 | 624 | 0.400 |
Why?
|
Disease Models, Animal | 3 | 2024 | 18255 | 0.330 |
Why?
|
Disease Progression | 1 | 2024 | 13510 | 0.280 |
Why?
|
MicroRNAs | 1 | 2021 | 3816 | 0.250 |
Why?
|
Mitochondria, Muscle | 1 | 2024 | 172 | 0.220 |
Why?
|
Colonic Neoplasms | 2 | 2024 | 2539 | 0.190 |
Why?
|
Hindlimb | 1 | 2023 | 513 | 0.190 |
Why?
|
Mice, Transgenic | 2 | 2024 | 9542 | 0.180 |
Why?
|
Mice | 7 | 2024 | 81539 | 0.180 |
Why?
|
Reactive Oxygen Species | 1 | 2024 | 2139 | 0.130 |
Why?
|
Fibrosis | 1 | 2023 | 2049 | 0.130 |
Why?
|
Animals | 7 | 2024 | 168475 | 0.120 |
Why?
|
Hypertrophy | 1 | 2016 | 561 | 0.120 |
Why?
|
Motor Neurons | 1 | 2019 | 870 | 0.120 |
Why?
|
Mitochondria | 2 | 2024 | 3624 | 0.110 |
Why?
|
Aorta, Thoracic | 1 | 2016 | 1096 | 0.080 |
Why?
|
Exercise | 2 | 2016 | 5890 | 0.080 |
Why?
|
Exercise Test | 1 | 2016 | 2127 | 0.080 |
Why?
|
Cell Line, Tumor | 1 | 2024 | 16990 | 0.070 |
Why?
|
Adenocarcinoma | 1 | 2024 | 6345 | 0.070 |
Why?
|
Male | 6 | 2024 | 360846 | 0.060 |
Why?
|
Endothelium, Vascular | 1 | 2016 | 4431 | 0.060 |
Why?
|
Blood Pressure | 2 | 2016 | 8481 | 0.060 |
Why?
|
Ultrasonography | 1 | 2016 | 5971 | 0.050 |
Why?
|
Cross-Over Studies | 2 | 2016 | 2079 | 0.040 |
Why?
|
Muscle Weakness | 1 | 2022 | 412 | 0.040 |
Why?
|
Hydrogen Peroxide | 1 | 2022 | 730 | 0.040 |
Why?
|
Atrophy | 1 | 2022 | 1633 | 0.040 |
Why?
|
Female | 3 | 2024 | 392705 | 0.030 |
Why?
|
Neoplasms | 1 | 2023 | 22173 | 0.030 |
Why?
|
Humans | 5 | 2023 | 761596 | 0.030 |
Why?
|
Young Adult | 2 | 2016 | 59260 | 0.030 |
Why?
|
Vasculitis | 1 | 2016 | 521 | 0.020 |
Why?
|
Weight Loss | 1 | 2023 | 2684 | 0.020 |
Why?
|
Aged | 1 | 2023 | 169310 | 0.020 |
Why?
|
Cardiovascular Diseases | 1 | 2016 | 15502 | 0.020 |
Why?
|
Interleukin-17 | 1 | 2016 | 912 | 0.020 |
Why?
|
Adult | 2 | 2016 | 221210 | 0.010 |
Why?
|